The Fraunhofer ITEM Division of Personalized Tumor Therapy in Regensburg aims to understand a patient’s individual condition, establish appropriate diagnostics, advance prevention and optimize therapies.
Our researchers develop methods for preparation, analysis and visualization of biomedical data, as well as data models and data analysis pipelines. The focus is on the mapping of cellular and regulatory processes and their translation into applications.
Based on the next generation risk assessment concept, Fraunhofer ITEM develops new assessment strategies to provide predictive models for assessing the safety of compounds, active pharmaceutical ingredients and drugs.
Our Annual Report allows you to get an insight into our research activities and objectives, but also into the way we work and the people behind all this.
Our Annual Report each year gives an account of the work done in our different business areas and of selected research results.
If you prefer to read a printed version of our Annual Report, please subscribe to the printed version. We will be pleased to send you a copy and hope you will enjoy reading it.
A chapter in our Annual Report documents the "Names, dates and facts" for this particular year. For up-to-date informationen in the individual subject areas, please click below on the corresponding link: